v3.26.1
Basic and Diluted Loss Per Share - Schedule of Dilutive Common Share Equivalents Outstanding Excluded in Diluted Net Loss Per Share Calculation (Details) - shares
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Schedule of Dilutive Common Share Equivalents Outstanding Excluded in Diluted Net Loss Per Share Calculation [Line Items]        
Total 12,573,861 14,972,926 12,573,861 14,972,926
Earnout Shares [Member]        
Schedule of Dilutive Common Share Equivalents Outstanding Excluded in Diluted Net Loss Per Share Calculation [Line Items]        
Total [1] 2,100,000 2,100,000
Warrant [Member]        
Schedule of Dilutive Common Share Equivalents Outstanding Excluded in Diluted Net Loss Per Share Calculation [Line Items]        
Total [2] 12,145,917 12,145,917 12,145,917 12,145,917
RSUs [Member]        
Schedule of Dilutive Common Share Equivalents Outstanding Excluded in Diluted Net Loss Per Share Calculation [Line Items]        
Total [2] 427,944 727,009 427,944 727,009
[1] As described in Note 4 - Reverse recapitalization, the Earnout Shares that are contingently issuable in connection with the Business Combination are subject to vesting based on the Company’s financial performance during the earnout period. The Earnout Shares are excluded from the calculation of basic and diluted weighted-average number of common shares outstanding until vested.
[2] The Company’s outstanding warrants and RSUs were excluded from the computation of diluted EPS because it has anti-dilutive effect as the company had a net loss during the periods presented.